Table 2.
Pooled prevalence of relative adrenal insufficiency in non-critically patients with cirrhosis
| Analysis | Pooled Prevalence (95% CI) |
|---|---|
| Overall | 37% (33–42%) |
| By Child-Pugh Classification | |
| Child-Pugh A | 27% (16–38%) |
| Child-Pugh B | 39% (28–50%) |
| Child-Pugh C | 64% (58–71%) |
| By Type of ACTH Stimulation Test | |
| SD-SST | 34% (28–41%) |
| LD-SST | 44% (36–52%) |
| By Diagnostic Threshold | |
| Peak total cortisol < 18 μg/dL | 29% (23–35%) |
| Delta total cortisol < 9 μg/dL | 36% (28–45%) |
| Peak free cortisol < 1.2 μg/dL | 12% (4–20%) |
| Salivary cortisol (composite)† | 19% (13–25%) |
| By Illness Acuity | |
| Stable outpatient | 33% (21–45%) |
| Hospitalized, non-critically ill | 38% (34–43%) |
Abbreviations: ACTH, adrenocorticotropic hormone; SD-SST, standard-dose short synacthen test; LD-SST, low-dose short synacthen test.
Composite of baseline salivary cortisol < 0.2 μg/dL, peak salivary cortisol < 1.3 μg/dL, or delta salivary cortisol < 0.3 μg/dL.